Triamterene And Hydrochlorothiazide Tablet
Product Images NDC 71335-2338

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 71335-2338). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352338)

Triamterene and Hydrochlorothiazide Tablets USP 75 mg/50 mg label showing the prescription drug with 30 oral tablets in the package. The label specifies repackaging by Bryant Ranch Prepack and manufacturing by Rubicon Research Private Limited. Storage instructions and safety warnings are also present.*

FDA Label Image

Triamterene Structural Formula (Triamterene Hctz Tabs Usp Structure 1)

Chemical structure of Triamterene, showing its molecular framework with fused heterocyclic rings and an attached phenyl group.*

FDA Label Image

Hydrochlorothiazide Structural Formula (Triamterene Hctz Tabs Usp Structure 2)

Chemical structure of Triamterene, showing its molecular framework including a chlorinated benzene ring, sulfonamide group, and heterocyclic components. The structure is consistent with the active ingredient Triamterene in the combined oral tablet formulation with Hydrochlorothiazide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.